Cardiología
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (72)
2024
-
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Journal of Clinical Medicine, Vol. 13, Núm. 9
-
Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry
Revista Espanola de Cardiologia
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182
-
Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97
-
Prevalence of Fabry disease in patients with left ventricular hypertrophy and renal involvement (PrEFaCe)
Medicina Clinica
-
Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial
Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460
-
Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort
International Journal of Cardiology, Vol. 405
-
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score
European Journal of Internal Medicine, Vol. 124, pp. 108-114
-
Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)
Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946
2023
-
Changes in the Treatment Strategy Following Intracoronary Pressure Wire in a Contemporaneous Real-Life Cohort of Patients With Intermediate Coronary Stenosis. Results From a Nationwide Registry
Cardiovascular Revascularization Medicine, Vol. 51, pp. 55-64
-
Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19
Journal of Clinical Medicine, Vol. 12, Núm. 11
-
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
Journal of Clinical Medicine, Vol. 12, Núm. 12
-
Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
Journal of Clinical Medicine, Vol. 12, Núm. 16
-
Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study
European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360
-
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry
ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204
-
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
Patient Preference and Adherence, Vol. 17, pp. 839-849
-
Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
Clinical Cardiology, Vol. 46, Núm. 11, pp. 1390-1397
-
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)
Journal of Clinical Medicine, Vol. 12, Núm. 2
-
Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry
Frontiers in Endocrinology, Vol. 14
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031